Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jashodeep Datta

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Journal of Surgical Oncology|September 24, 2015
Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomesBrett L Ecker, Jashodeep Datta, Matthew T McMillan, et al.
Annals of Surgical Oncology|June 24, 2015
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on SurvivalLea Lowenfeld, Jashodeep Datta, Russell S Lewis, et al.
Cancer|December 31, 2015
Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysisBrett L Ecker, Matthew T McMillan, Jashodeep Datta, et al.
Annals of Surgical Oncology|April 20, 2016
Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United StatesJashodeep Datta, Matthew T McMillan, Luis Ruffolo, et al.
Breast Cancer Research : BCR|May 23, 2015
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancerJashodeep Datta, Erik Berk, Shuwen Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design TrialLea Lowenfeld, Rosemarie Mick, Jashodeep Datta, et al.
Gastro Hep Advances|December 15, 2023
Colorectal Cancer Immunotherapy: State of the Art and Future DirectionsAlyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2025
Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancerNilesh U Deshpande, Anna Bianchi, Haleh Amirian, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2015
Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric CancerMatthew T McMillan, Eric Ojerholm, Robert E Roses, et al.
Annals of Surgery|July 3, 2015
Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched AnalysisJashodeep Datta, Matthew T McMillan, Brett L Ecker, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Journal of Surgical Oncology|September 24, 2015
Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomesBrett L Ecker, Jashodeep Datta, Matthew T McMillan, et al.
Annals of Surgical Oncology|June 24, 2015
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on SurvivalLea Lowenfeld, Jashodeep Datta, Russell S Lewis, et al.
Cancer|December 31, 2015
Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysisBrett L Ecker, Matthew T McMillan, Jashodeep Datta, et al.
Annals of Surgical Oncology|April 20, 2016
Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United StatesJashodeep Datta, Matthew T McMillan, Luis Ruffolo, et al.
Breast Cancer Research : BCR|May 23, 2015
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancerJashodeep Datta, Erik Berk, Shuwen Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design TrialLea Lowenfeld, Rosemarie Mick, Jashodeep Datta, et al.
Gastro Hep Advances|December 15, 2023
Colorectal Cancer Immunotherapy: State of the Art and Future DirectionsAlyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2025
Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancerNilesh U Deshpande, Anna Bianchi, Haleh Amirian, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2015
Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric CancerMatthew T McMillan, Eric Ojerholm, Robert E Roses, et al.
Annals of Surgery|July 3, 2015
Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched AnalysisJashodeep Datta, Matthew T McMillan, Brett L Ecker, et al.
Pageof 14